Consistent with an MYCN-ALYREF-USP3 signal driving neuroblastoma tumorigenesis, we found that high USP3 mRNA expression in the SEQC neuroblastoma patient cohort (n = 498) also correlated with poor prognosis (Fig. 6a and Supplementary Fig. 6a). The gene discussed is MYCN; the disease is neuroblastoma.